VXA-CoV2-1.1-S
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VXA-CoV2-1.1-S, covering 2024-06-21 to 2024-06-21. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults and Boost (VXA-CoV2-1.1-S) at 1 Year Post Initial Vaccination in Subset of Subjects [Phase 1]